Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,894 public trials 2,121 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

NCT05604560

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations: Johns Hopkins SKCCC Baltimore, Maryland, United States

The University of Texas Health Science Center San Antonio San Antonio, Texas, United States

View Trial Details

Active, not recruiting

Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.

NCT06020885

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Sun yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer

NCT07074535

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cranial Nerve Diseases, +29 more
Locations: Daping Hospital Chongqing, China

View Trial Details

Active, not recruiting

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

NCT06248528

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China Wuhan, Hubei, China

View Trial Details

Active, not recruiting

PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma

NCT04907370

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China

First People's Hospital of Foshan Foshan, Guangdong, China

Panyu central hospital Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy

NCT07065786

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Zhongda hospital Changzhou, Jiangsu, China

View Trial Details

Active, not recruiting

Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level

NCT07062211

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +11 more
Locations: INMOL hospital Lahore, Punjab Province, Pakistan

View Trial Details

Active, not recruiting

A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.

NCT07060248

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Second Xiangya Hospital Changsha, Hunan, China

View Trial Details

Active, not recruiting

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

NCT00365157

Conditions: Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +9 more
Locations: Tower Cancer Research Foundation Beverly Hills, California, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

City of Hope Antelope Valley Lancaster, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View all 26 locations

View Trial Details

Active, not recruiting

Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma

NCT07047001

Conditions: Adenocarcinoma, Adjuvant, Carcinoma, +15 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions